Description FDA is expected to endorse Duchenne muscular dystrophy treatment, as safety concerns linger over uses of viruses FDA is expected to endorse Duchenne muscular dystrophy treatment, as safety concerns… Click to show full abstract
Description FDA is expected to endorse Duchenne muscular dystrophy treatment, as safety concerns linger over uses of viruses FDA is expected to endorse Duchenne muscular dystrophy treatment, as safety concerns linger over uses of viruses
Keywords:
milestone looms;
gene therapy;
field seeks;
seeks better;
looms field;
therapy milestone
Journal Title: Science
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Science
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!